Kaouthar Lbiati
Director/Board Member at HEPION PHARMACEUTICALS, INC.
Net worth: - $ as of 29/04/2024
Kaouthar Lbiati active positions
Companies | Position | Start | End |
---|---|---|---|
HEPION PHARMACEUTICALS, INC. | Director/Board Member | 26/06/2022 | - |
Independent Dir/Board Member | 26/06/2022 | - | |
THERALASE TECHNOLOGIES INC. | Director/Board Member | 05/06/2023 | - |
Independent Dir/Board Member | 05/06/2023 | - | |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Career history of Kaouthar Lbiati
Former positions of Kaouthar Lbiati
Companies | Position | Start | End |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Steba Biotech SA
Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Steba Biotech SA is a Luxembourger biotechnology company that focuses on developing therapies to combat cancer. The private company is based in Luxembourg, Luxembourg. | Corporate Officer/Principal | - | - |
Training of Kaouthar Lbiati
London School of Economics & Political Science | Graduate Degree |
ESSEC Business School | Graduate Degree |
Mohammed V University | Doctorate Degree |
Statistics
International
United States | 4 |
2 | |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
HEPION PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
Theralase Technologies, Inc. | |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Steba Biotech SA
Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Steba Biotech SA is a Luxembourger biotechnology company that focuses on developing therapies to combat cancer. The private company is based in Luxembourg, Luxembourg. | Commercial Services |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Kaouthar Lbiati
- Experience